Caroline Godfrey
Overview
Explore the profile of Caroline Godfrey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
1216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marmor H, Kammer M, Deppen S, Shipe M, Welty V, Patel K, et al.
J Thorac Cardiovasc Surg
. 2023 Feb;
166(3):669-678.e4.
PMID: 36792410
Objective: Indeterminate pulmonary nodules (IPNs) represent a significant diagnostic burden in health care. We aimed to compare a combination clinical prediction model (Mayo Clinic model), fungal (histoplasmosis serology), imaging (computed...
2.
Gait M, Arzumanov A, McClorey G, Godfrey C, Betts C, Hammond S, et al.
Nucleic Acid Ther
. 2018 Oct;
29(1):1-12.
PMID: 30307373
The review starts with a historical perspective of the achievements of the Gait group in synthesis of oligonucleotides (ONs) and their peptide conjugates toward the award of the 2017 Oligonucleotide...
3.
Betts C, McClorey G, Healicon R, Hammond S, Manzano R, Muses S, et al.
Hum Mol Genet
. 2018 Oct;
28(3):396-406.
PMID: 30281092
Duchenne muscular dystrophy (DMD) is caused by loss of dystrophin protein, leading to progressive muscle weakness and premature death due to respiratory and/or cardiac complications. Cardiac involvement is characterized by...
4.
Coenen-Stass A, Sork H, Gatto S, Godfrey C, Bhomra A, Krjutskov K, et al.
Mol Ther Nucleic Acids
. 2018 Sep;
13:1-15.
PMID: 30219269
Extracellular small RNAs (sRNAs), including microRNAs (miRNAs), are promising biomarkers for diseases such as Duchenne muscular dystrophy (DMD), although their biological relevance is largely unknown. To investigate the relationship between...
5.
Blain A, Greally E, McClorey G, Manzano R, Betts C, Godfrey C, et al.
PLoS One
. 2018 Jun;
13(6):e0198897.
PMID: 29912990
Cardiac failure is a major cause of mortality in patients with Duchenne muscular dystrophy (DMD). Antisense-mediated exon skipping has the ability to correct out-of-frame mutations in DMD to produce truncated...
6.
Godfrey C, Desviat L, Smedsrod B, Pietri-Rouxel F, Denti M, Disterer P, et al.
EMBO Mol Med
. 2017 Mar;
9(5):545-557.
PMID: 28289078
The use of splice-switching antisense therapy is highly promising, with a wealth of pre-clinical data and numerous clinical trials ongoing. Nevertheless, its potential to treat a variety of disorders has...
7.
Ebbels S, Wright L, Brockbank S, Godfrey C, Harris C, Leniston H, et al.
Int J Lang Commun Disord
. 2016 Nov;
52(4):528-539.
PMID: 27859986
Background: Evidence of the effectiveness of therapy for older children with (developmental) language disorder (DLD), and particularly those with receptive language impairments, is very limited. The few existing studies have...
8.
Roberts T, Johansson H, McClorey G, Godfrey C, Blomberg K, Coursindel T, et al.
Hum Mol Genet
. 2015 Sep;
24(23):6756-68.
PMID: 26385637
Duchenne muscular dystrophy (DMD) is a classical monogenic disorder, a model disease for genomic studies and a priority candidate for regenerative medicine and gene therapy. Although the genetic cause of...
9.
Betts C, Saleh A, Carr C, Muses S, Wells K, Hammond S, et al.
Sci Rep
. 2015 Jun;
5:11632.
PMID: 26113184
Duchenne muscular dystrophy (DMD) is caused by absence of the integral structural protein, dystrophin, which renders muscle fibres susceptible to injury and degeneration. This ultimately results in cardiorespiratory dysfunction, which...
10.
Godfrey C, Muses S, McClorey G, Wells K, Coursindel T, Terry R, et al.
Hum Mol Genet
. 2015 May;
24(15):4225-37.
PMID: 25935000
Splice modulation therapy has shown great clinical promise in Duchenne muscular dystrophy, resulting in the production of dystrophin protein. Despite this, the relationship between restoring dystrophin to established dystrophic muscle...